
Texas-based writer and Senior Editor at Baylor College of Medicine’s Center for Cell and Gene Therapy, Catherine Gillespie is ready to help you tell your scientific story.
Science writing combines Catherine’s curiosity and love of language. She intended to study biology and pursue genetic research at Duke University but fell in love with Dostoevsky in her Russian novel course. After graduating with a major in Slavic Languages and Literatures and minors in Economics and English, Catherine moved first to New York City for a brief stint at a biotech hedge fund before settling in Moscow to work as a journalist.
That learning Russian was more fun for Catherine than balancing chemical equations makes her a better editor — five years working abroad taught her the unique challenges of writing in your non-native language.
Catherine has edited original manuscripts and reviews on topics ranging from immunotherapy to speech pathology that have been published in Science, Nature, Cell Stem Cell, Nature Biotechnology, PNAS, Journal of Clinical Oncology, Nature Medicine, Cell Reports, Blood, and Neuron, among many others.
She has worked with scientists at all levels — from biotech companies to faculty investigators to graduate students — on successful grants for National Institutes of Health, Food and Drug Administration, Cancer Prevention and Research Institute of Texas, as well as organizations like Alex’s Lemonade Stand and Howard Hughes Medical Institute.
Catherine serves on the American Society of Gene and Cell Therapy Communications Committee and has taught and lectured on a variety of writing-related topics across the Texas Medical Center.
A Few Manuscripts Catherine Edited and Revised






Blood, DOT1L as a therapeutic target for the treatment of DNMT3A-mutant acute myeloid leukemia
Cell Reports, Pancreatic Cell Fate Determination Relies on Notch Ligand Trafficking by NFIA
